Literature DB >> 19631283

An association between microscopic colitis and celiac disease.

Peter H R Green1, Jun Yang, Jianfeng Cheng, Anne R Lee, Jason W Harper, Govind Bhagat.   

Abstract

BACKGROUND & AIMS: Microscopic colitis has been associated with celiac disease. We aimed to determine the extent and significance of this relationship.
METHODS: A prospectively maintained database of celiac disease patients, seen between 1981 and 2006, was analyzed. Standardized morbidity ratios (SMR) were calculated using a general population study of microscopic colitis as the reference group. Statistical analysis was conducted using the Student t test, Pearson chi(2) test, or Fisher exact test.
RESULTS: Microscopic colitis was found in 44 of 1009 patients (4.3%); this represented a 70-fold increased risk for individuals with celiac disease to have microscopic colitis, compared with the general population (SMR, 72.39; 95% confidence interval [CI], 52.52-95.36). The celiac disease patients with microscopic colitis were older (P = .0001) and had more severe villous atrophy (P = .002) than the celiac disease patients without microscopic colitis. Microscopic colitis was diagnosed after celiac disease in 64% of the patients, simultaneously in 25%, and before celiac disease in 11% (P = .0001). Pancolitis predominated, though 16% had colitis limited to the right colon. Steroid or immunosuppressant therapies were required in 66% of the celiac disease patients with microscopic colitis and given as maintenance therapy to 50% of these patients. Follow-up biopsies revealed that the colitis persisted in 57% of the patients with celiac disease and microscopic colitis, despite improved diarrhea symptoms; the diarrhea resolved in most of the patients.
CONCLUSIONS: Microscopic colitis is more common in patients with celiac disease than in the general population. Patients with celiac disease and microscopic colitis have more severe villous atrophy and frequently require steroids or immunosuppressant therapies to control diarrhea.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631283     DOI: 10.1016/j.cgh.2009.07.011

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  34 in total

Review 1.  Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded.

Authors:  Tze S Khor; Hiroshi Fujita; Koji Nagata; Michio Shimizu; Gregory Y Lauwers
Journal:  J Gastroenterol       Date:  2012-02-10       Impact factor: 7.527

Review 2.  Current Approach to the Evaluation and Management of Microscopic Colitis.

Authors:  Thomas G Cotter; Darrell S Pardi
Journal:  Curr Gastroenterol Rep       Date:  2017-02

Review 3.  Review of the microscopic colitides.

Authors:  Eugene F Yen; Darrell S Pardi
Journal:  Curr Gastroenterol Rep       Date:  2011-10

4.  Expression Profiling of Inflammatory and Immunological Genes in Collagenous Colitis.

Authors:  Qingqing Liu; Noam Harpaz
Journal:  J Crohns Colitis       Date:  2019-05-27       Impact factor: 9.071

Review 5.  Microscopic colitis (lymphocytic and collagenous), eosinophilic colitis, and celiac disease.

Authors:  M Sophia Villanueva; Yewande Alimi
Journal:  Clin Colon Rectal Surg       Date:  2015-06

6.  Necessary additional points.

Authors:  Andreas Tromm
Journal:  Dtsch Arztebl Int       Date:  2014-03-21       Impact factor: 5.594

Review 7.  Diagnosis and Management of Microscopic Colitis.

Authors:  Darrell S Pardi
Journal:  Am J Gastroenterol       Date:  2016-11-29       Impact factor: 10.864

Review 8.  Microscopic colitis: diagnosis and management.

Authors:  Tristan Townsend; Fiona Campbell; Paul O'Toole; Chris Probert
Journal:  Frontline Gastroenterol       Date:  2018-11-27

9.  Microscopic Colitis: A Review of Collagenous and Lymphocytic Colitis.

Authors:  Karen Boland; Geoffrey C Nguyen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-11

10.  ACG clinical guidelines: diagnosis and management of celiac disease.

Authors:  Alberto Rubio-Tapia; Ivor D Hill; Ciarán P Kelly; Audrey H Calderwood; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2013-04-23       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.